The molecular mechanisms controlling the pathological symptoms of VWM can be investigated by identifying changes in protein expression caused by mutations in EIF2B. In some previous studies, proteomics approaches were used to investigate the molecular mechanisms affecting VWM [6,7,8]. This evidence concerns the gene EIF2B1 and leukoencephalopathy with vanishing white matter.